International Meeting for Autism Research
International Meeting for Autism Research
The International Meeting for Autism Research (IMFAR) is an annual scientific conference dedicated to advancing the understanding of autism spectrum disorder (ASD). It serves as a platform for researchers, clinicians, and other stakeholders to share the latest findings and developments in the field of autism research.
History[edit | edit source]
IMFAR was first established in 2001 by the International Society for Autism Research (INSAR). The meeting was created to provide a forum for the exchange of ideas and collaboration among researchers from various disciplines involved in autism research.
Objectives[edit | edit source]
The primary objectives of IMFAR are to:
- Facilitate the dissemination of cutting-edge research findings related to autism.
- Foster interdisciplinary collaboration among researchers, clinicians, and other professionals.
- Promote the translation of research into practice to improve outcomes for individuals with autism and their families.
Conference Structure[edit | edit source]
IMFAR typically features a variety of sessions, including:
- Keynote addresses by leading experts in the field.
- Symposia that focus on specific topics within autism research.
- Poster sessions where researchers present their latest findings.
- Workshops designed to provide hands-on learning experiences.
Topics Covered[edit | edit source]
The conference covers a wide range of topics, including but not limited to:
- Genetics and neuroscience of autism.
- Behavioral interventions and therapies.
- Diagnosis and assessment of autism.
- Social skills and communication in individuals with autism.
- Policy and advocacy related to autism.
Impact[edit | edit source]
IMFAR has significantly contributed to the advancement of autism research by:
- Providing a platform for the presentation of novel research findings.
- Encouraging collaboration and networking among researchers and practitioners.
- Influencing policy and practice through the dissemination of research.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
